Marlio Charles Mosseri is > 10% Shareholder of Nuvectis Pharma, Inc.. Currently has a direct ownership of 2.61 Million shares of NVCT, which is worth approximately $13.2 Million. The most recent transaction as insider was on Dec 13, 2024, when has been sold 17,000 shares (Common Stock) at a price of $4.7 per share, resulting in proceeds of $79,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.61M
0.66% 3M change
0.66% 12M change
Total Value Held $13.2 Million

Marlio Charles Mosseri Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2024
BUY
Open market or private purchase
$79,900 $4.7 p/Share
17,000 Added 0.65%
2,612,000 Common Stock
Jul 31 2023
BUY
Open market or private purchase
$11,936 $13.88 p/Share
860 Added 0.03%
2,595,000 Common Stock
Jul 28 2023
BUY
Open market or private purchase
$35,943 $13.91 p/Share
2,584 Added 0.1%
2,594,140 Common Stock
Jul 27 2023
BUY
Open market or private purchase
$21,752 $13.98 p/Share
1,556 Added 0.06%
2,591,556 Common Stock
Jul 26 2023
BUY
Open market or private purchase
$139,700 $13.97 p/Share
10,000 Added 0.38%
2,590,000 Common Stock
Jul 21 2023
BUY
Open market or private purchase
$41,550 $14.61 p/Share
2,844 Added 0.11%
2,580,000 Common Stock
Jul 20 2023
BUY
Open market or private purchase
$77,673 $14.4 p/Share
5,394 Added 0.21%
2,577,156 Common Stock
Jul 19 2023
BUY
Open market or private purchase
$118,720 $14.84 p/Share
8,000 Added 0.31%
2,571,762 Common Stock
Jul 18 2023
BUY
Open market or private purchase
$135,771 $14.84 p/Share
9,149 Added 0.36%
2,563,762 Common Stock
Jul 12 2023
BUY
Open market or private purchase
$49,570 $15.09 p/Share
3,285 Added 0.13%
2,554,613 Common Stock
Jul 11 2023
BUY
Open market or private purchase
$153,600 $15.36 p/Share
10,000 Added 0.39%
2,551,328 Common Stock
Jul 07 2023
BUY
Open market or private purchase
$135,920 $15.19 p/Share
8,948 Added 0.35%
2,541,328 Common Stock
Jul 06 2023
BUY
Open market or private purchase
$47,716 $15.01 p/Share
3,179 Added 0.13%
2,532,380 Common Stock
Jul 05 2023
BUY
Open market or private purchase
$18,251 $15.52 p/Share
1,176 Added 0.05%
2,529,201 Common Stock
Jun 26 2023
BUY
Open market or private purchase
$275,869 $16.46 p/Share
16,760 Added 0.66%
2,528,025 Common Stock
Jun 23 2023
BUY
Open market or private purchase
$1,275,440 $17.43 p/Share
73,175 Added 2.83%
2,511,265 Common Stock
Jun 22 2023
BUY
Open market or private purchase
$124,092 $17.73 p/Share
6,999 Added 0.29%
2,438,090 Common Stock
Jun 21 2023
BUY
Open market or private purchase
$107,871 $17.71 p/Share
6,091 Added 0.25%
2,431,091 Common Stock
Jun 16 2023
BUY
Open market or private purchase
$225,425 $17.75 p/Share
12,700 Added 0.52%
2,425,000 Common Stock
Jun 15 2023
BUY
Open market or private purchase
$566,346 $17.63 p/Share
32,124 Added 1.31%
2,412,300 Common Stock
MCM

Marlio Charles Mosseri

> 10% Shareholder
London, N1

Track Institutional and Insider Activities on NVCT

Follow Nuvectis Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCT shares.

Notify only if

Insider Trading

Get notified when an Nuvectis Pharma, Inc. insider buys or sells NVCT shares.

Notify only if

News

Receive news related to Nuvectis Pharma, Inc.

Track Activities on NVCT